Science & Enterprise subscription

Follow us on Twitter

  • Voice telephone, who knew? ... Why the Phone Is Key to Getting Covid Shots in Arms https://t.co/zf0KWGX7Ca
    about 23 mins ago
  • Israel is emerging as the world's leader in vaccinating its population, and seeing results in declines of new Covid… https://t.co/FBswRzZQld
    about 4 hours ago
  • New post on Science and Enterprise: Infographic – Israel Halts Covid-19 Spread with Vaccines https://t.co/ezP927woim #Science #Business
    about 5 hours ago
  • We wrote about this project last July. Read about it first on Science & Enterprise. ... Researchers Are Hatching a… https://t.co/rujRcnlZax
    about 8 hours ago
  • A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery… https://t.co/AzEb3ERy5f
    about 23 hours ago

Please share Science & Enterprise

Covid-19 Vaccines, Therapies – 3 August 2020

Vaccine and therapy tracker

BioRender Covid-19 vaccine and therapy tracker. (BioRender.com)

3 Aug. 2020. A continuing feature on Science & Enterprise is a weekly statistical report of vaccines and therapies for Covid-19 offered by BioRender, a scientific illustration software company. BioRender, in Toronto, Ontario, develops graphics tools for life sciences, biotechnology, and other disciplines.

Over the past week, seven more therapy candidates entered clinical trials bringing that number to 259, while the number of therapies in development remained the same at 337. And as reported last week, the numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 and 35 respectively.

In addition to the summary dashboard shown above, the BioRender Covid-19 vaccine and therapy page provides details of the vaccines and therapies, as well as an activity feed showing news updates on these drugs.

A front-page story this morning in the New York Times tells about political pressures on U.S. health agencies to take short cuts to approve a Covid-19 vaccine before the 2020 election in November. These short cuts include bypassing FDA’s advisory committees that review evidence and recommend actions by the agency, an almost unprecedented step for a drug of this magnitude. The implications are immense, including for trust in other vaccines and therapies needing FDA approval.

More from Science & Enterprise:

*     *     *

2 comments to Covid-19 Vaccines, Therapies – 3 August 2020